Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-05 · accession 0001209191-23-002543 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-09 | 2023-01-05 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale+OE | $12.07 | -111.0K | 712.4K | -13% | -$1.34M |
| D | 2023-01-09 | 2023-01-05 | IRWD | MCCOURT Thomas A | CEO, Dir | M - OptEx | $11.65 | +111.0K | 823.4K | +16% | +$1.29M |
| D | 2023-01-09 | 2023-01-05 | IRWD | MCCOURT Thomas A | CEO, Dir | M - OptEx | $0.00 | -111.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-01-05 | S | D | 110,962 | $12.07 | 712,440 | D | — | — | (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.01 to $12.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 2 | Common | Class A Common Stock | 2023-01-05 | M | A | 110,962 | $11.65 | 823,402 | D | — | — | |
| 3 | Derivative | Employee Stock Options (Right to Buy) | 2023-01-05 | M | D | 110,962 | $0.00 | 0 | D | $11.65 · — to 2023-02-01 | 110,962 Class A Common Stock | (F3) The options, vested as to 1.25% on each monthly anniversary of the vesting commencement date for the first 36 months, and as to 4.5833% of the award on each monthly anniversary thereafter, are presently exercisable in full. |